Henderson Group »

Lexeo Therapeutics shares owned by Henderson Group

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Henderson Group from 13F filings

Historical chart of Henderson Group investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Henderson Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Henderson Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $40M 2.5M 15.67
2023-12-31 $32M 2.3M 13.50

More positions owned by Henderson Group

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Mastercard Incorporated Cl A (MA)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Abbvie (ABBV)
Lam Research Corporation (LRCX)
Booking Holdings (BKNG)
Progressive Corporation (PGR)
Oracle Corporation (ORCL)
Deere & Company (DE)

View all positions for Henderson Group

Top funds holding Lexeo Therapeutics

Eventide Asset Management
Henderson Group
Citadel Advisors
Omega Fund Management
Adage Capital Partners GP
Braidwell
Artal Group
Blackstone Group
BlackRock
RA Capital Management
Millennium Management
Vanguard Group
Laurion Capital Management
Geode Capital Management
Cornell University

View all funds holding Lexeo Therapeutics